116 related articles for article (PubMed ID: 18314624)
21. Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue.
Schmidt RL; Park CH; Ahmed AU; Gundelach JH; Reed NR; Cheng S; Knudsen BE; Tang AH
Cancer Res; 2007 Dec; 67(24):11798-810. PubMed ID: 18089810
[TBL] [Abstract][Full Text] [Related]
22. Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes.
Bruzzoni-Giovanelli H; Fernandez P; Veiga L; Podgorniak MP; Powell DJ; Candeias MM; Mourah S; Calvo F; Marín M
J Exp Clin Cancer Res; 2010 Feb; 29(1):10. PubMed ID: 20144232
[TBL] [Abstract][Full Text] [Related]
23. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
[TBL] [Abstract][Full Text] [Related]
24. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
25. The substrate binding domains of human SIAH E3 ubiquitin ligases are now crystal clear.
Zhang Q; Wang Z; Hou F; Harding R; Huang X; Dong A; Walker JR; Tong Y
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3095-3105. PubMed ID: 27776223
[TBL] [Abstract][Full Text] [Related]
26. SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.
Buchwald M; Pietschmann K; Brand P; Günther A; Mahajan NP; Heinzel T; Krämer OH
Oncogene; 2013 Oct; 32(41):4913-20. PubMed ID: 23208506
[TBL] [Abstract][Full Text] [Related]
27. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
[TBL] [Abstract][Full Text] [Related]
28. An N-terminal SIAH-interacting motif regulates the stability of the ubiquitin specific protease (USP)-19.
Velasco K; Zhao B; Callegari S; Altun M; Liu H; Hassink G; Masucci MG; Lindsten K
Biochem Biophys Res Commun; 2013 Apr; 433(4):390-5. PubMed ID: 23500468
[TBL] [Abstract][Full Text] [Related]
29. Siah-1 interacts with the intracellular region of polycystin-1 and affects its stability via the ubiquitin-proteasome pathway.
Kim H; Jeong W; Ahn K; Ahn C; Kang S
J Am Soc Nephrol; 2004 Aug; 15(8):2042-9. PubMed ID: 15284290
[TBL] [Abstract][Full Text] [Related]
30. Inactivating mutations of the Siah-1 gene in gastric cancer.
Kim CJ; Cho YG; Park CH; Jeong SW; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park WS
Oncogene; 2004 Nov; 23(53):8591-6. PubMed ID: 15467739
[TBL] [Abstract][Full Text] [Related]
31. SIAH proteins: critical roles in leukemogenesis.
Krämer OH; Stauber RH; Bug G; Hartkamp J; Knauer SK
Leukemia; 2013 Apr; 27(4):792-802. PubMed ID: 23038274
[TBL] [Abstract][Full Text] [Related]
32. Structure-based design of covalent Siah inhibitors.
Stebbins JL; Santelli E; Feng Y; De SK; Purves A; Motamedchaboki K; Wu B; Ronai ZA; Liddington RC; Pellecchia M
Chem Biol; 2013 Aug; 20(8):973-82. PubMed ID: 23891150
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.
Franck T; Krueger R; Woitalla D; Müller T; Engelender S; Riess O
J Neural Transm (Vienna); 2006 Dec; 113(12):1903-8. PubMed ID: 16752048
[TBL] [Abstract][Full Text] [Related]
34. SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis.
Germani A; Bruzzoni-Giovanelli H; Fellous A; Gisselbrecht S; Varin-Blank N; Calvo F
Oncogene; 2000 Dec; 19(52):5997-6006. PubMed ID: 11146551
[TBL] [Abstract][Full Text] [Related]
35. PKC phosphorylation regulates mGluR5 trafficking by enhancing binding of Siah-1A.
Ko SJ; Isozaki K; Kim I; Lee JH; Cho HJ; Sohn SY; Oh SR; Park S; Kim DG; Kim CH; Roche KW
J Neurosci; 2012 Nov; 32(46):16391-401. PubMed ID: 23152621
[TBL] [Abstract][Full Text] [Related]
36. Siah: a promising anticancer target.
Wong CS; Möller A
Cancer Res; 2013 Apr; 73(8):2400-6. PubMed ID: 23455005
[TBL] [Abstract][Full Text] [Related]
37. siah-1 Protein is necessary for high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation and cell death in Muller cells.
Yego EC; Mohr S
J Biol Chem; 2010 Jan; 285(5):3181-90. PubMed ID: 19940145
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of ubiquitin ligase Siah-1A by disabled-1.
Park TJ; Hamanaka H; Ohshima T; Watanabe N; Mikoshiba K; Nukina N
Biochem Biophys Res Commun; 2003 Mar; 302(4):671-8. PubMed ID: 12646221
[TBL] [Abstract][Full Text] [Related]
39. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
40. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
Guo Y; Wang J; Zhang L; Shen S; Guo R; Yang Y; Chen W; Wang Y; Chen G; Shuai X
Hepatology; 2016 Apr; 63(4):1240-55. PubMed ID: 26680504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
